Back to dashboard
Episode 628
DIP Episode 628 - USMLE Step 2/3 Rapid Review Series 131
MixedMedium4 - HighHas Q&A
Step 1Step 2Step 3COMLEXMedicineUSMLEStep 1Step 2Step 3
Topic
Diabetic gastroparesis; Autoimmune disease associations; GI malabsorption (Gastric bypass)...
Key Takeaway
When managing diabetic gastroparesis, the first-line prokinetic agent is metoclopramide (a D2 antagonist), but clinicians must monitor for tardive dyskinesia and neuroleptic malignant syndrome (NMS), which can present with rhabdomyolysis and hyperkalemia.
Runtime: 22 min
Published: 2026-01-17
Completed audio: Yes
Completed notes: Yes
Anki made: Yes
Section: RAPID REVIEW SERIES
Episode Notes
Source / episode info
- Episode: 628
- Title: DIP Ep 628: USMLE Step 2/3 Rapid Review Series 131
- Published: 2026-01-17
- Source: Episode page
One-liner
This episode provides a high-yield review of diabetic gastroparesis management using prokinetic agents like metoclopramide (D2 antagonist) and erythromycin (motilin agonist), while also integrating concepts of GI malabsorption following gastric bypass leading to iron deficiency anemia, which is associated with restless legs syndrome, porphyria cutanea tarda, and polycythemia vera.
High-yield summary
- Diabetic Gastroparesis: Characterized by delayed gastric emptying due to autonomic neuropathy (often diabetic). Diagnosis requires a gastric emptying study; initial management involves prokinetic agents.
- Metoclopramide Use: Metoclopramide is a D2 receptor antagonist and effective for gastroparesis, but its use carries risks of tardive dyskinesia and neuroleptic malignant syndrome (NMS).
- NMS/Rhabdomyolysis Cascade: NMS can present with severe muscle rigidity and fever. The resulting rhabdomyolysis releases myoglobin into the bloodstream, causing acute kidney injury (AKI) and potentially life-threatening hyperkalemia.
- Gastric Bypass & Iron Deficiency: Bypassing the duodenum (the primary site of iron absorption) leads to malabsorption and subsequent iron deficiency anemia. This is a critical complication requiring close follow-up and supplementation.
- Iron Deficiency Syndromes: Low iron stores are key determinants in several conditions: 1) Restless Legs Syndrome (RLS), 2) Porphyria Cutanea Tarda (PCT, where bleeding helps symptoms), and 3) Polycythemia Vera (PV, where menstrual blood loss can improve symptoms).
Learning objectives
- Differentiate the clinical presentation and management of diabetic gastroparesis.
- Recognize the side effects associated with prokinetic agents (e.g., metoclopramide).
- Understand the metabolic cascade linking rhabdomyolysis, NMS, and hyperkalemia.
- Identify common causes of malabsorption following GI surgery (e.g., gastric bypass) and their specific deficiencies.
- Correlate iron deficiency with multiple systemic conditions (RLS, PCT, PV).
Board exam buzzwords
| Condition | Key Finding | Association | Board Exam Tip |
| Diabetic Gastroparesis | Early satiety, vomiting after meals | Autonomic neuropathy (diabetes) | Always suspect this in a diabetic patient presenting with GI symptoms. Test for delayed gastric emptying. |
| Metoclopramide | Tardive Dyskinesia; NMS | Dopamine (D2) receptor antagonist | Remember the side effects of anti-psychotics/prokinetics. Discontinue pro-kinetics if SBO is suspected due to rupture risk. |
| Iron Deficiency Anemia | Low serum ferritin | Gastric bypass, heavy menses, malabsorption | Check ferritin when GI surgery or chronic blood loss is present; treat with supplemental iron for RLS. |
| Porphyria Cutanea Tarda (PCT) | Skin fragility, hypertrichosis | Increased activity of uroporphyrinogen decarboxylase by iron deficiency/bleeding | Bleeding (phlebotomy) is a therapeutic intervention that improves symptoms. Screen for Hepatitis C. |
Rapid review table
| Topic | Key Point | Context | Exam Relevance |
| Gastric Emptying Study | Delayed gastric emptying time | Suspected gastroparesis (e.g., diabetic) | Confirms the diagnosis; guides prokinetic agent use. |
| Metoclopramide | D2 receptor antagonist | Prokinetic therapy for gastroparesis | High risk of TD and NMS. Must be used cautiously, especially in SBO. |
| Gastric Bypass | Bypasses duodenum/jejunum | Malabsorption (especially iron) | Leads to chronic iron deficiency anemia; requires lifelong follow-up and supplementation. |
| Restless Legs Syndrome (RLS) | Symptoms worsen at night, urge to move legs | Strong association with low ferritin/iron stores | Check serum ferritin in any patient presenting with RLS + GI malabsorption risk factors. |
Board-speak -> diagnosis
| Board-speak / Vignette phrase | Diagnosis / Concept | Why it fits |
| A diabetic patient presents with early satiety, postprandial vomiting, and abdominal pain. | Diabetic Gastroparesis | Autonomic neuropathy (diabetic) impairs GI motility, leading to delayed gastric emptying. |
| A patient on metoclopramide develops involuntary, repetitive movements of the tongue and face months after starting the drug. | Tardive Dyskinesia | Metoclopramide is a dopamine (D2) receptor antagonist; chronic blockade leads to extrapyramidal symptoms. |
| A patient with NMS presents with muscle rigidity and red urine. | Rhabdomyolysis/Myoglobinuria | Severe muscle breakdown releases myoglobin, which can precipitate AKI and cause hyperkalemia. The red color is due to myoglobin, not hemoglobin. |
| A patient who underwent gastric bypass develops iron deficiency anemia and restless legs syndrome. | Iron Malabsorption / Restless Legs Syndrome (RLS) | Gastric bypass bypasses the duodenum, impairing iron absorption; RLS has a strong association with low ferritin/iron stores. |
| A porphyria patient's symptoms improve after significant blood loss. | Porphyria Cutanea Tarda (PCT) | PCT treatment involves inducing iron deficiency (e.g., phlebotomy), which increases the activity of uroporphyrinogen decarboxylase. |
| A woman with polycythemia vera presents later in life than men, and her symptoms are exacerbated by menstruation. | Polycythemia Vera (PV) / Menstrual Cycle | The cyclical blood loss during menses helps reduce iron stores, which can temporarily alleviate PV symptoms due to the underlying pathophysiology involving iron regulation. |
Differential diagnosis / distinguishing features
Causes of Iron Deficiency Anemia
| Key Features | Distinguishing Findings | Next Step |
| Gastric Bypass/Malabsorption | Bypasses duodenum (primary iron absorption site) | History of GI surgery; low serum ferritin. |
| Heavy Menstrual Bleeding | Chronic blood loss from menses | High menstrual flow volume, lack of other sources of bleeding. |
Management pearls
- Gastroparesis: If the patient has a suspected small bowel obstruction (SBO), discontinue prokinetic agents like metoclopramide due to increased risk of bowel rupture.
- Metoclopramide Side Effects: Be aware that D2 receptor antagonists can cause both tardive dyskinesia and NMS.
- Iron Deficiency Treatment: For RLS secondary to iron deficiency, the primary treatment is supplemental oral or IV iron (not just treating the symptoms).
- Porphyria/PV Bleeding: In patients with PCT or PV, bleeding (phlebotomy) can be a therapeutic intervention because it induces mild iron deficiency, which increases the activity of uroporphyrinogen decarboxylase.
Don't miss
🚨
Gastric Bypass Anatomy: The procedure bypasses the duodenum and proximal jejunum, leading to malabsorption of nutrients like iron.
🚨
NMS Mechanism: NMS is associated with rhabdomyolysis -> myoglobinuria (red urine) -> AKI and hyperkalemia due to massive intracellular potassium release.
🚨
Prokinetic Agent Choice: Metoclopramide (D2 antagonist) is first line, but erythromycin (motilin agonist) is a viable second option; however, be aware of the risk of tachyphylaxis with macrolides.
🚨
Iron Deficiency Syndromes: Always consider iron deficiency as the underlying cause when RLS, PCT, or PV are presented in conjunction with GI malabsorption or chronic blood loss.
Integration & clinical reasoning
- GI Surgery & Nutrition: Gastric bypass is a classic example of how surgical alteration of anatomy (bypassing duodenum) leads to specific nutritional deficiencies (iron). This requires lifelong follow-up and supplementation protocols.
- Pharmacology & Neurology: Metoclopramide demonstrates the principle that a drug used for GI motility can cause severe neurological side effects (TD, NMS) because its mechanism targets neurotransmitter receptors (D2 antagonism).
- Hematology & Metabolism: The common thread linking PCT, PV, and RLS is iron metabolism. Iron deficiency acts as an enzyme cofactor or metabolic trigger in these disparate conditions.
OMM / COMLEX integration
🦴
For COMLEX: know these viscerosomatics / Chapman points, but don't let OMM distract from emergent diagnosis and management.
- Standard emergency management for NMS or rhabdomyolysis takes priority over OMT; stabilization with IV calcium gluconate and aggressive fluid resuscitation is critical.
- The concept of metabolic triggers (like iron deficiency in PCT) can be integrated into understanding how systemic deficiencies affect enzyme function, which relates to the body's overall homeostatic mechanisms.
Concept connections / cross-references
- For detailed information on the pathophysiology of autoimmune diseases and their screening protocols, see [Episode 13].
- For a comprehensive review of GI anatomy and surgical complications, see [Episode 45].
High-yield association table
| Condition | Association | Mechanism | Clinical Significance |
| Diabetic Gastroparesis | Early satiety, vomiting after meals | Autonomic neuropathy (diabetes) -> impaired peristalsis | Requires diagnosis via gastric emptying study; management is complex due to drug side effects. |
| Metoclopramide | Tardive Dyskinesia / NMS | Dopamine (D2) receptor blockade | Monitor for extrapyramidal symptoms and discontinue if SBO is suspected. |
| Gastric Bypass | Iron Deficiency Anemia | Bypassing the duodenum (primary site of iron absorption) | Requires mandatory lifelong follow-up and supplementation with iron/multivitamins. |
| Porphyria Cutanea Tarda (PCT) | Bleeding / Phlebotomy | Induces mild iron deficiency, increasing uroporphyrinogen decarboxylase activity | A key diagnostic pearl: symptoms improve after blood loss. Screen for Hepatitis C. |
Key terms glossary
| Term | Definition | Context | Example |
| Gastroparesis | Delayed gastric emptying due to impaired GI motility. | Diabetic patients, post-surgical states. | Symptoms include early satiety and vomiting shortly after meals. |
| D2 Receptor Antagonist | A drug that blocks dopamine D2 receptors. | Metoclopramide (prokinetic agent). | Used to stimulate gut motility but carries risk of extrapyramidal symptoms. |
| Rhabdomyolysis | Breakdown of skeletal muscle tissue releasing intracellular contents. | Severe trauma, NMS, prolonged immobility. | Leads to myoglobinuria (red urine) and acute kidney injury; causes hyperkalemia. |
| Ferritin | A protein that stores iron in the body. | Lab test for assessing total body iron stores. | Low ferritin levels are highly predictive of iron deficiency anemia and associated syndromes. |
Study optimization
| Topic | Study Approach | Priority | Resources |
| GI Motility Disorders | Focus on etiology (diabetic vs mechanical) and drug mechanisms/side effects. | High | Review prokinetic agents (Metoclopramide, Erythromycin) side effect profiles. |
| Malabsorption Syndromes | Link surgical bypass sites to specific nutrient deficiencies (e.g., duodenum -> iron). | Medium-High | Create a flow chart: Surgery -> Bypassed Area -> Deficiency -> Syndrome. |
| Iron Metabolism Pearls | Memorize the three conditions (RLS, PCT, PV) that improve with blood loss/iron deficiency. | High | Use mnemonics to link low ferritin to these specific syndromes. |
Question pattern recognition
- Pattern: Diabetic GI Symptoms: Early satiety, vomiting after meals -> Gastroparesis. Next step is a gastric emptying study.
- Pattern: Iron Deficiency + RLS: Restless legs syndrome in the setting of malabsorption (e.g., post-gastric bypass) or heavy menses -> Check serum ferritin and supplement iron.
- Pattern: NMS/Rhabdomyolysis: High fever, muscle rigidity, red urine, elevated creatinine -> Think rhabdomyolysis leading to hyperkalemia; treat with IV calcium gluconate first.
Test yourself
Common mistakes to avoid
🚫
Mistake 1: Confusing GI Obstruction vs. Gastroparesis: A patient with SBO needs NPO and decompression, but gastroparesis requires prokinetic agents (if no obstruction). Never give a prokinetic agent if mechanical bowel obstruction is suspected due to rupture risk.
🚫
Mistake 2: Misinterpreting Iron Deficiency in PCT/PV: Assuming iron deficiency only causes anemia; remember it can be a therapeutic factor that improves symptoms of porphyria and polycythemia vera by increasing enzyme activity.
🚫
Mistake 3: Overlooking the Duodenum's Role: When considering malabsorption after gastric bypass, always recall that the duodenum is the primary site for iron absorption, making this deficiency highly likely.
Common traps
⚠️
Trap 1 (The "Best" Test): Do not assume endoscopy or CT are sufficient for gastroparesis; a functional test (gastric emptying study) is required.
⚠️
Trap 2 (Iron Supplementation): When treating RLS secondary to iron deficiency, the goal is to restore stores, so supplemental iron is needed, even if other causes of anemia exist.
⚠️
Trap 3 (Prokinetic Agent Use): Never use a prokinetic agent in the setting of suspected small bowel obstruction because it increases the risk of perforation/rupture.